We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+15.29%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$1.85B
AUM Growth
+$69.7M
Cap. Flow
-$150M
Cap. Flow %
-8.07%
Top 10 Hldgs %
12.74%
Holding
850
New
84
Increased
223
Reduced
387
Closed
155
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATM
301
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$1.86M 0.1%
52,223
-10,342
-17% -$308K
SGEN
302
DELISTED
Seagen Inc. Common Stock
SGEN
$1.86M 0.1%
25,343
-650
-3% -$46.3K
PNW icon
303
Pinnacle West Capital
PNW
$12.2B
$1.85M 0.1%
19,373
+11,460
+145% +$1.03M
MAR icon
304
Marriott International
MAR
$92.3B
$1.85M 0.1%
14,787
+2,265
+18% +$267K
VSH icon
305
Vishay Intertechnology
VSH
$5.43B
$1.85M 0.1%
100,119
-9,441
-9% -$189K
VIAB
306
DELISTED
Viacom Inc. Class B
VIAB
$1.84M 0.1%
65,727
+15,911
+32% +$457K
CRTO icon
307
Criteo S.A. Ordinary Shares
CRTO
$923M
$1.84M 0.1%
91,851
+6,292
+7% +$160K
BRW
308
Saba Capital Income & Opportunities Fund
BRW
$339M
$1.83M 0.1%
+191,920
New +$1.82M
REGN icon
309
Regeneron Pharmaceuticals
REGN
$80.8B
$1.82M 0.1%
4,433
-88
-2% -$36.2K
ONC
310
BeOne Medicines Ltd
ONC
$39.4B
$1.82M 0.1%
13,780
-295
-2% -$39.8K
AMN icon
311
AMN Healthcare
AMN
$1.4B
$1.8M 0.1%
38,289
-9,607
-20% -$533K
TIER
312
DELISTED
TIER REIT, Inc.
TIER
$1.76M 0.1%
+61,479
New +$1.46M
ECHO
313
EchoStar
ECHO
$26.2B
$1.72M 0.09%
58,144
+20,201
+53% +$637K
ALLO icon
314
Allogene Therapeutics
ALLO
$694M
$1.72M 0.09%
59,330
-1,352
-2% -$39.2K
SANM icon
315
Sanmina
SANM
$10.9B
$1.7M 0.09%
58,974
-1,472
-2% -$43.4K
FATE icon
316
Fate Therapeutics
FATE
$326M
$1.69M 0.09%
96,315
-3,479
-3% -$54.9K
MRNA icon
317
Moderna
MRNA
$23.6B
$1.68M 0.09%
82,315
-2,075
-2% -$38.5K
EIX icon
318
Edison International
EIX
$26.4B
$1.66M 0.09%
26,886
-26,069
-49% -$1.56M
ABBV icon
319
AbbVie
ABBV
$435B
$1.66M 0.09%
20,547
+397
+2% +$32.5K
SKYW icon
320
Skywest
SKYW
$4.34B
$1.66M 0.09%
30,483
-760
-2% -$39K
JNJ icon
321
Johnson & Johnson
JNJ
$625B
$1.65M 0.09%
11,779
-2,749
-19% -$368K
HIW icon
322
Highwoods Properties
HIW
$3.47B
$1.64M 0.09%
35,084
+8,101
+30% +$361K
HOUS
323
DELISTED
Anywhere Real Estate
HOUS
$1.64M 0.09%
143,527
+17,701
+14% +$273K
AZN icon
324
AstraZeneca
AZN
$250B
$1.63M 0.09%
20,165
-43
-0.2% -$3.39K
ES icon
325
Eversource Energy
ES
$27.2B
$1.63M 0.09%
22,992
+2,190
+11% +$151K

Similar funds

Vident Investment Advisory's Q1 2019 Portfolio in Review

As of Q1 2019, Vident Investment Advisory held 850 positions worth $1.85B, up 3.9% from $1.79B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory withdrew a net $150M in Q1 2019, closing 155 positions and reducing 387 holdings. Its most notable exit was ABB Ltd, an estimated $12.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Nuveen Preferred & Income Securities Fund worth $9.58M.

  • Vident Investment Advisory's largest Q1 2019 buy was Nuveen Preferred & Income Securities Fund: 1,064,354 shares worth $9.58M.
  • Vident Investment Advisory added most to AllianceBernstein Global High Income Fund in Q1 2019, an estimated $5.65M increase.
  • Vident Investment Advisory's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17M.
  • Vident Investment Advisory fully exited ABB Ltd in Q1 2019, selling an estimated $12.2M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $1.85B portfolio in Q1 2019.
  • Vident Investment Advisory opened 84 new positions and closed 155 in Q1 2019.
  • Vident Investment Advisory's portfolio value rose 3.9% quarter-over-quarter to $1.85B.

Based on Vident Investment Advisory's 13F filing for Q1 2019, filed 8 May 2019.